Blogs & Articles

Altria Becomes Largest Shareholder in Cronos Group, A Leading Global Cannabinoid Company

VIRGINIA: Altria announced the completion of its approximately USD $1.8 billion (CAD $2.4 billion) investment in Cronos Group, a leading global cannabinoid company, following receipt of shareholder and Canadian regulatory approvals. Altria’s investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership at a price of CAD $19.00 Read the full article...
Harvest Health & Recreation to Acquire Verano, Cre...
FDA Commissioner’s Resignation Prompts Uncertainty...